• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌细胞内在收缩性和钙处理缺陷是癌症恶病质小鼠心脏器官功能障碍的基础。

Cardiac myocyte intrinsic contractility and calcium handling deficits underlie heart organ dysfunction in murine cancer cachexia.

机构信息

Nutrition Sciences Division, Department of Human Sciences and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, TX, USA.

Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.

出版信息

Sci Rep. 2021 Dec 8;11(1):23627. doi: 10.1038/s41598-021-02688-z.

DOI:10.1038/s41598-021-02688-z
PMID:34880268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8655071/
Abstract

Cachexia is a muscle wasting syndrome occurring in many advanced cancer patients. Cachexia significantly increases cancer morbidity and mortality. Cardiac atrophy and contractility deficits have been observed in patients and in animal models with cancer cachexia, which may contribute to cachexia pathophysiology. However, underlying contributors to decreased in vivo cardiac contractility are not well understood. In this study, we sought to distinguish heart-intrinsic changes from systemic factors contributing to cachexia-associated cardiac dysfunction. We hypothesized that isolated heart and cardiac myocyte functional deficits underlie in vivo contractile dysfunction. To test this hypothesis, isolated heart and cardiac myocyte function was measured in the colon-26 adenocarcinoma murine model of cachexia. Ex vivo perfused hearts from cachectic animals exhibited marked contraction and relaxation deficits during basal and pacing conditions. Isolated myocytes displayed significantly decreased peak contraction and relaxation rates, which was accompanied by decreased peak calcium and decay rates. This study uncovers significant organ and cellular-level functional deficits in cachectic hearts outside of the catabolic in vivo environment, which is explained in part by impaired calcium cycling. These data provide insight into physiological mechanisms of cardiomyopathy in cachexia, which is critical for the ultimate development of effective treatments for patients.

摘要

恶病质是一种发生在许多晚期癌症患者中的肌肉消耗综合征。恶病质显著增加了癌症的发病率和死亡率。在患有恶病质的癌症患者和动物模型中,已经观察到心脏萎缩和收缩功能缺陷,这可能导致恶病质的病理生理学发生。然而,导致体内心脏收缩力下降的潜在因素尚不清楚。在这项研究中,我们试图区分导致恶病质相关心脏功能障碍的心脏内在变化和系统性因素。我们假设孤立心脏和心肌细胞功能缺陷是导致体内收缩功能障碍的基础。为了验证这一假设,我们在结肠-26 腺癌恶病质的小鼠模型中测量了孤立心脏和心肌细胞的功能。在基础和起搏条件下,来自恶病质动物的离体心脏表现出明显的收缩和舒张功能障碍。分离的心肌细胞的峰值收缩和舒张速度明显降低,同时伴有峰值钙和衰减速度降低。这项研究揭示了恶病质心脏在代谢环境之外的明显器官和细胞水平的功能缺陷,这部分是由钙循环受损引起的。这些数据为恶病质性心肌病的生理机制提供了深入的了解,这对于最终为患者开发有效的治疗方法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/0787ba82676f/41598_2021_2688_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/1bb5a5fc6591/41598_2021_2688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/0a2d05279b52/41598_2021_2688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/c11381aa97fe/41598_2021_2688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/1bcf4a5f11b7/41598_2021_2688_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/22ecbde4c836/41598_2021_2688_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/0787ba82676f/41598_2021_2688_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/1bb5a5fc6591/41598_2021_2688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/0a2d05279b52/41598_2021_2688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/c11381aa97fe/41598_2021_2688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/1bcf4a5f11b7/41598_2021_2688_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/22ecbde4c836/41598_2021_2688_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/509e/8655071/0787ba82676f/41598_2021_2688_Fig6_HTML.jpg

相似文献

1
Cardiac myocyte intrinsic contractility and calcium handling deficits underlie heart organ dysfunction in murine cancer cachexia.心肌细胞内在收缩性和钙处理缺陷是癌症恶病质小鼠心脏器官功能障碍的基础。
Sci Rep. 2021 Dec 8;11(1):23627. doi: 10.1038/s41598-021-02688-z.
2
Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors.癌症恶病质中心脏重构:功能、结构和代谢的贡献者。
Cells. 2022 Jun 15;11(12):1931. doi: 10.3390/cells11121931.
3
Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca cycling in vivo.肌营养不良性心肌病的恶化由磷酸甘油酸变位酶缺乏介导的慢性增加的心脏 Ca 循环引起。
Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1544-H1552. doi: 10.1152/ajpheart.00341.2018. Epub 2018 Aug 17.
4
Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.醋酸甲地孕酮通过自噬调节改善癌症恶病质诱导性心肌病模型的心脏功能。
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):555-566. doi: 10.1002/jcsm.12116. Epub 2016 Apr 7.
5
Reverse remodeling and recovery from cachexia in rats with aldosteronism.醛固酮增多症大鼠的逆向重构和恶病质恢复。
Am J Physiol Heart Circ Physiol. 2012 Aug 15;303(4):H486-95. doi: 10.1152/ajpheart.00192.2012. Epub 2012 Jun 22.
6
Cancer cachexia decreases specific force and accelerates fatigue in limb muscle.癌症恶病质降低肢体肌肉的比肌力并加速疲劳。
Biochem Biophys Res Commun. 2013 Jun 7;435(3):488-92. doi: 10.1016/j.bbrc.2013.05.018. Epub 2013 May 11.
7
Pathophysiology of peripheral muscle wasting in cardiac cachexia.心脏恶病质中周围肌肉萎缩的病理生理学
Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54. doi: 10.1097/01.mco.0000165002.08955.5b.
8
Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support.尽管左心室辅助装置支持改善了心肌结构,但心肌收缩功能仍未完全恢复。
Circ Heart Fail. 2011 Jul;4(4):425-32. doi: 10.1161/CIRCHEARTFAILURE.111.961326. Epub 2011 May 3.
9
Cardiac alterations in cancer-induced cachexia in mice.癌症恶病质导致的小鼠心脏改变。
Int J Oncol. 2010 Aug;37(2):347-53. doi: 10.3892/ijo_00000683.
10
Skeletal muscle derived Musclin protects the heart during pathological overload.肌生成素可在病理性过载时保护心脏
Nat Commun. 2022 Jan 10;13(1):149. doi: 10.1038/s41467-021-27634-5.

引用本文的文献

1
Cardioprotection of voluntary exercise against breast cancer-induced cardiac injury via STAT3.通过信号转导和转录激活因子3(STAT3)介导,自愿运动对乳腺癌诱导的心脏损伤具有心脏保护作用。
Basic Res Cardiol. 2025 Feb;120(1):113-131. doi: 10.1007/s00395-024-01076-8. Epub 2024 Aug 19.
2
Unraveling the lost balance: Adrenergic dysfunction in cancer cachexia.解析失衡之谜:癌症恶病质中的肾上腺素能功能障碍。
Auton Neurosci. 2024 Feb;251:103136. doi: 10.1016/j.autneu.2023.103136. Epub 2023 Dec 6.
3
The pathophysiology of cancer-mediated cardiac cachexia and novel treatment strategies: A narrative review.

本文引用的文献

1
Cancer-induced Cardiac Atrophy Adversely Affects Myocardial Redox State and Mitochondrial Oxidative Characteristics.癌症诱导的心脏萎缩对心肌氧化还原状态和线粒体氧化特性产生不利影响。
JCSM Rapid Commun. 2021 Jan-Jun;4(1):3-15. doi: 10.1002/rco2.18. Epub 2020 Aug 7.
2
Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness.对线粒体功能和活性氧生成进行药理学靶向治疗可预防结肠26癌诱发的心肺肌无力。
Oncotarget. 2020 Sep 22;11(38):3502-3514. doi: 10.18632/oncotarget.27748.
3
Management of Cancer Cachexia: ASCO Guideline.
癌症导致的心脏恶病质的病理生理学和新的治疗策略:一篇叙述性综述。
Cancer Med. 2023 Sep;12(17):17706-17717. doi: 10.1002/cam4.6388. Epub 2023 Sep 1.
4
The oxidative aging model integrated various risk factors in type 2 diabetes mellitus at system level.该氧化衰老模型在系统水平上综合了 2 型糖尿病的各种危险因素。
Front Endocrinol (Lausanne). 2023 May 24;14:1196293. doi: 10.3389/fendo.2023.1196293. eCollection 2023.
5
Does Myocardial Atrophy Represent Anti-Arrhythmic Phenotype?心肌萎缩是否代表抗心律失常表型?
Biomedicines. 2022 Nov 4;10(11):2819. doi: 10.3390/biomedicines10112819.
6
Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors.癌症恶病质中心脏重构:功能、结构和代谢的贡献者。
Cells. 2022 Jun 15;11(12):1931. doi: 10.3390/cells11121931.
癌症恶病质的管理:ASCO 指南。
J Clin Oncol. 2020 Jul 20;38(21):2438-2453. doi: 10.1200/JCO.20.00611. Epub 2020 May 20.
4
Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.肺癌患者左心室质量的快速萎缩。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1070-1082. doi: 10.1002/jcsm.12451. Epub 2019 Jul 10.
5
Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma.霍奇金淋巴瘤患者心脏代谢转换的证据。
ESC Heart Fail. 2019 Aug;6(4):824-829. doi: 10.1002/ehf2.12475. Epub 2019 Jul 6.
6
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.在美国和欧盟中癌症恶病质的孤儿病地位:系统评价。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):22-34. doi: 10.1002/jcsm.12402.
7
Inter-tissue communication in cancer cachexia.癌症恶病质中的组织间通讯。
Nat Rev Endocrinol. 2018 Dec;15(1):9-20. doi: 10.1038/s41574-018-0123-0.
8
Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.心脏肿瘤学:心脏病学领域中一个新兴且发展中的研究和治疗领域。
Heart Fail Rev. 2019 Jan;24(1):91-100. doi: 10.1007/s10741-018-9731-y.
9
Metabolic remodelling in heart failure.心力衰竭中的代谢重编程。
Nat Rev Cardiol. 2018 Aug;15(8):457-470. doi: 10.1038/s41569-018-0044-6.
10
Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression.癌症恶病质中骨骼肌和心肌的蛋白质组学分析:肌节和线粒体蛋白表达的改变
Oncotarget. 2018 Apr 24;9(31):22001-22022. doi: 10.18632/oncotarget.25146.